Invivogen
Menu

InvivoGen's product citations

Citations

InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).

Citations search

You can search by ‘Product Name’ or ‘Year’.

Find a citation by product name
Enter a year of publication
Product Citation Year Journal Authors Page
2'3'-cGAMP Human in vitro modeling identifies adjuvant combinations that unlock antigen ... 2024 J Mol Biol. Thomas S. et al. DOI: 10.1016/j.jmb.2024.168446
3p-hpRNA - RIG-I agonist Human in vitro modeling identifies adjuvant combinations that unlock antigen ... 2024 J Mol Biol. Thomas S. et al. DOI: 10.1016/j.jmb.2024.168446
Poly(I:C) HMW Human in vitro modeling identifies adjuvant combinations that unlock antigen ... 2024 J Mol Biol. Thomas S. et al. DOI: 10.1016/j.jmb.2024.168446
TDB Human in vitro modeling identifies adjuvant combinations that unlock antigen ... 2024 J Mol Biol. Thomas S. et al. DOI: 10.1016/j.jmb.2024.168446
CL264 Human in vitro modeling identifies adjuvant combinations that unlock antigen ... 2024 J Mol Biol. Thomas S. et al. DOI: 10.1016/j.jmb.2024.168446
Puromycin Oral cancer cell to endothelial cell communication via exosomal miR-21/RMND5A... 2024 BMC Oral Health Sun Y.Q. et al. DOI: 10.1186/s12903-024-03852-3
QUANTI-Blue™ Uptake of Cyclodextrin Nanoparticles by Macrophages is Dependent on Particle ... 2024 ACS Appl Bio Mater. Soni S.S. et al. DOI: 10.1021/acsabm.3c00985
RAW-Blue™ Cells Uptake of Cyclodextrin Nanoparticles by Macrophages is Dependent on Particle ... 2024 ACS Appl Bio Mater. Soni S.S. et al. DOI: 10.1021/acsabm.3c00985
ODN 1826 VacciGrade™ Vaccine design via antigen reorientation. 2024 Nat Chem Biol. Xu D. et al. DOI: 10.1038/s41589-023-01529-6
Alhydrogel® adjuvant 2% Vaccine design via antigen reorientation. 2024 Nat Chem Biol. Xu D. et al. DOI: 10.1038/s41589-023-01529-6
G418 (Geneticin) Lymphocyte-Specific Protein 1 Regulates Expression and Stability of Endotheli... 2024 Biomolecules Smeir M. et al. DOI: 10.3390/biom14010111
QUANTI-Blue™ Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... 2024 ACS Nano Ou B.S. et al. DOI: 10.1021/acsnano.3c09700
RAW-Blue™ Cells Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... 2024 ACS Nano Ou B.S. et al. DOI: 10.1021/acsnano.3c09700
Human TLR9 Reporter THP-1 Cells Nanoparticle-Conjugated Toll-Like Receptor 9 Agonists Improve the Potency, Du... 2024 ACS Nano Ou B.S. et al. DOI: 10.1021/acsnano.3c09700
QUANTI-Luc™: Luciferase Detection Reagent Gel-mediated recruitment of conventional type 1 dendritic cells potentiates t... 2024 Biomaterials Wu Y. et al. DOI: 10.1016/j.biomaterials.2024.122470
293-Dual™ mSTING Cells Gel-mediated recruitment of conventional type 1 dendritic cells potentiates t... 2024 Biomaterials Wu Y. et al. DOI: 10.1016/j.biomaterials.2024.122470
Zeocin® A novel, robust peptidyl-lys metalloendopeptidase from Trametes coccinea reco... 2024 Appl Microbiol Biotechnol. Ahmed U. et al. DOI: 10.1007/s00253-023-12986-3
Poly(I:C) HMW UNC93B1 variants underlie TLR7-dependent autoimmunity. 2024 Sci Immunol. Wolf C. et al. DOI: 10.1126/sciimmunol.adi9769
Puromycin Comparison of antibody-based immunotherapeutics for malignant hematological d... 2024 Blood Adv. Albring J.C. et al. DOI: 10.1182/bloodadvances.2023011647
Primocin® Organoids derived from patients provide a new opportunity for research and in... 2024 Mol Cancer Fang X. et al. DOI: 10.1186/s12943-023-01901-z

Pages

Customer Service
& Technical Support
Contact us
Shopping cart is empty